The Middle EAST Meibomian Gland Dysfunction Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. This growth trajectory is underpinned by increasing awareness of eye health issues, rising prevalence of dry eye syndrome, and advancements in treatment options. The demand for effective therapeutic solutions is further fueled...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek